The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis

Pieter Janssen, M. Scott Harris, Mike Jones, Tatsuhiro Masaoka, Ricard Farré, Hans Törnblom, Lukas Van Oudenhove, Magnus Simrén, Jan Tack

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

OBJECTIVES:The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies.METHODS:The MEDLINE database (1,946 to present) was searched, and only controlled trials or trials with an established effective comparator that compared both SI and GE were included.RESULTS:Studies were identified for metoclopramide (n=6), domperidone (n=6), cisapride (n=14), erythromycin (n=3), botulinum toxin (n=2), and levosulpiride (n=3). Even though most drugs concomitantly improved symptoms and accelerated GE, no study reported a significant correlation between SI and GE. Moreover, a correlation analysis over all studies using meta-regression did not show a significant relationship between SI and GE. Our findings need to be qualified by inconsistencies in study methods, which is a limitation but also suggests that our findings are robust to methodological factors.CONCLUSIONS:In this review, no evidence of a relationship between SI and GE was identified for different drugs used for the treatment of gastroparesis. This finding questions the use of GE measurement to direct drug development for gastroparesis.

Original languageEnglish
Pages (from-to)1382-1391
Number of pages10
JournalAmerican Journal of Gastroenterology
Volume108
Issue number9
DOIs
Publication statusPublished - 2013 Sep
Externally publishedYes

Fingerprint

Gastroparesis
Gastric Emptying
Pharmaceutical Preparations
Cisapride
Domperidone
Metoclopramide
Botulinum Toxins
Erythromycin
MEDLINE
Meta-Analysis
Regression Analysis
Databases

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. / Janssen, Pieter; Scott Harris, M.; Jones, Mike; Masaoka, Tatsuhiro; Farré, Ricard; Törnblom, Hans; Van Oudenhove, Lukas; Simrén, Magnus; Tack, Jan.

In: American Journal of Gastroenterology, Vol. 108, No. 9, 09.2013, p. 1382-1391.

Research output: Contribution to journalArticle

Janssen, P, Scott Harris, M, Jones, M, Masaoka, T, Farré, R, Törnblom, H, Van Oudenhove, L, Simrén, M & Tack, J 2013, 'The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis', American Journal of Gastroenterology, vol. 108, no. 9, pp. 1382-1391. https://doi.org/10.1038/ajg.2013.118
Janssen, Pieter ; Scott Harris, M. ; Jones, Mike ; Masaoka, Tatsuhiro ; Farré, Ricard ; Törnblom, Hans ; Van Oudenhove, Lukas ; Simrén, Magnus ; Tack, Jan. / The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. In: American Journal of Gastroenterology. 2013 ; Vol. 108, No. 9. pp. 1382-1391.
@article{4d87ece977a344c2ada8e0a175dae411,
title = "The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis",
abstract = "OBJECTIVES:The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies.METHODS:The MEDLINE database (1,946 to present) was searched, and only controlled trials or trials with an established effective comparator that compared both SI and GE were included.RESULTS:Studies were identified for metoclopramide (n=6), domperidone (n=6), cisapride (n=14), erythromycin (n=3), botulinum toxin (n=2), and levosulpiride (n=3). Even though most drugs concomitantly improved symptoms and accelerated GE, no study reported a significant correlation between SI and GE. Moreover, a correlation analysis over all studies using meta-regression did not show a significant relationship between SI and GE. Our findings need to be qualified by inconsistencies in study methods, which is a limitation but also suggests that our findings are robust to methodological factors.CONCLUSIONS:In this review, no evidence of a relationship between SI and GE was identified for different drugs used for the treatment of gastroparesis. This finding questions the use of GE measurement to direct drug development for gastroparesis.",
author = "Pieter Janssen and {Scott Harris}, M. and Mike Jones and Tatsuhiro Masaoka and Ricard Farr{\'e} and Hans T{\"o}rnblom and {Van Oudenhove}, Lukas and Magnus Simr{\'e}n and Jan Tack",
year = "2013",
month = "9",
doi = "10.1038/ajg.2013.118",
language = "English",
volume = "108",
pages = "1382--1391",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis

AU - Janssen, Pieter

AU - Scott Harris, M.

AU - Jones, Mike

AU - Masaoka, Tatsuhiro

AU - Farré, Ricard

AU - Törnblom, Hans

AU - Van Oudenhove, Lukas

AU - Simrén, Magnus

AU - Tack, Jan

PY - 2013/9

Y1 - 2013/9

N2 - OBJECTIVES:The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies.METHODS:The MEDLINE database (1,946 to present) was searched, and only controlled trials or trials with an established effective comparator that compared both SI and GE were included.RESULTS:Studies were identified for metoclopramide (n=6), domperidone (n=6), cisapride (n=14), erythromycin (n=3), botulinum toxin (n=2), and levosulpiride (n=3). Even though most drugs concomitantly improved symptoms and accelerated GE, no study reported a significant correlation between SI and GE. Moreover, a correlation analysis over all studies using meta-regression did not show a significant relationship between SI and GE. Our findings need to be qualified by inconsistencies in study methods, which is a limitation but also suggests that our findings are robust to methodological factors.CONCLUSIONS:In this review, no evidence of a relationship between SI and GE was identified for different drugs used for the treatment of gastroparesis. This finding questions the use of GE measurement to direct drug development for gastroparesis.

AB - OBJECTIVES:The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies.METHODS:The MEDLINE database (1,946 to present) was searched, and only controlled trials or trials with an established effective comparator that compared both SI and GE were included.RESULTS:Studies were identified for metoclopramide (n=6), domperidone (n=6), cisapride (n=14), erythromycin (n=3), botulinum toxin (n=2), and levosulpiride (n=3). Even though most drugs concomitantly improved symptoms and accelerated GE, no study reported a significant correlation between SI and GE. Moreover, a correlation analysis over all studies using meta-regression did not show a significant relationship between SI and GE. Our findings need to be qualified by inconsistencies in study methods, which is a limitation but also suggests that our findings are robust to methodological factors.CONCLUSIONS:In this review, no evidence of a relationship between SI and GE was identified for different drugs used for the treatment of gastroparesis. This finding questions the use of GE measurement to direct drug development for gastroparesis.

UR - http://www.scopus.com/inward/record.url?scp=84883728100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883728100&partnerID=8YFLogxK

U2 - 10.1038/ajg.2013.118

DO - 10.1038/ajg.2013.118

M3 - Article

C2 - 24005344

AN - SCOPUS:84883728100

VL - 108

SP - 1382

EP - 1391

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -